Download Citation
Article Source:
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data
Chen GF,
Wei L,
Chen J,
Duan ZP,
Dou XG,
et al.
(2016)
Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data.
PLOS ONE 11(6): e0155934.
https://doi.org/10.1371/journal.pone.0155934